Jean Chastre

Active 1981–2025

134
Papers
35,962
Citations
100
h-index
134
i10-index

Citations

Citations per year for Jean Chastre1982: 1 citations1983: 2 citations1984: 3 citations1985: 6 citations1986: 3 citations1987: 7 citations1988: 6 citations1989: 14 citations1990: 27 citations1991: 33 citations1992: 49 citations1993: 76 citations1994: 66 citations1995: 106 citations1996: 84 citations1997: 78 citations1998: 127 citations1999: 112 citations2000: 147 citations2001: 137 citations2002: 155 citations2003: 183 citations2004: 199 citations2005: 217 citations2006: 233 citations2007: 199 citations2008: 220 citations2009: 196 citations2010: 190 citations2011: 205 citations2012: 230 citations2013: 251 citations2014: 235 citations2015: 227 citations2016: 213 citations2017: 286 citations2018: 240 citations2019: 841 citations2020: 828 citations2021: 839 citations2022: 651 citations2023: 485 citations2024: 678 citations2025: 268 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,376 citing papers, 22.3% of this breakdownFrance: 1,083 citing papers, 10.2% of this breakdownSpain: 592 citing papers, 5.6% of this breakdownUnited Kingdom: 585 citing papers, 5.5% of this breakdownItaly: 547 citing papers, 5.1% of this breakdownChina: 490 citing papers, 4.6% of this breakdownGermany: 478 citing papers, 4.5% of this breakdownCanada: 459 citing papers, 4.3% of this breakdownAustralia: 370 citing papers, 3.5% of this breakdownNetherlands: 300 citing papers, 2.8% of this breakdownSwitzerland: 276 citing papers, 2.6% of this breakdownBelgium: 264 citing papers, 2.5% of this breakdown
0%22.3%Other 26.5%

Fields

  • Medicine66.2%
  • Engineering11.6%
  • Biochemistry, Genetics and Molecular Biology11.2%
  • Immunology and Microbiology6.4%
  • Environmental Science1%
  • Health Professions1%
  • Other2.6%

Topics

  • Nosocomial Infections in ICU11%
  • Sepsis Diagnosis and Treatment6.4%
  • Respiratory Support and Mechanisms6.3%
  • Antibiotic Resistance in Bacteria6%
  • Mechanical Circulatory Support Devices4.7%
  • Antibiotic Use and Resistance4.4%
  • Other61.2%

Coauthors

All papers

Open in search
  1. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 1,395

  2. Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults

    Authors: , , , , , , , , , , , , , - JAMA 2003 cited by 1,401

  3. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takaya Maruyama, Rosario Menéndez, Mark L. Metersky, Donna Mildvan, Eric M. Mortensen, Michael S. Niederman, Mathias W. Pletz, Jordi Rello, Marcos I. Restrepo, Yuichiro Shindo, Antoní Torres, Grant Waterer, Brandon Webb, Tobias Welte, Martin Witzenrath, Richard G. Wunderink - CHEST Journal 2020 cited by 233

  4. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

    Authors: , , , , , , , , , , , , , , , - The Lancet 2010 cited by 1,181

  5. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Oliver, Olivier Barraud, Terramika Bellamy, Marc J. M. Bonten, Herman Goossens, Colin Reisner, Mark T. Esser, Hasan S. Jafri, The COMBACTE-MAGNET EVADE Study Group, Michael Joannidis, Walter Klimscha, Elisabeth De Waele, Jacques Devriendt, Vincent Huberlant, Pieter Depuydt, Sam Van Boxstael, Mladen Perić, Jasminka Kopić, Michal Hanauer, Tomas Hruby, Vladimír Šrámek, Petr Svoboda, Tomáš Vymazal, Martin Nováček, Djillali Annane, Jean‐Paul Mira, Bertrand Souweine, Pierre‐François Dequin, Ferhat Meziani, François Stéphan, Saadalla Nseir, Sébastien Gibot, Carole Schwebel, Gaëtan Plantefève, Jean‐Luc Diehl, Christian Richard, Christian Lamer, Kada Klouche, Samir Jaber, Epaminondas Zakynthinos, Georgios Filntisis, Spyros Zakynthinos, Antonia Koutsoukou, Georgios Saroglou, Charikleia Nikolaou, Glykeria Vlachogianni, Ioannis Pnevmatikos, Konstantinos Mandragos, Ildikó Krémer, Zsolt Dezso Rozgonyi, Zsuzsa Marjanek, Ignacio Martín‐Loeches, Pierre Singer, Vernon van Heerden, Yehuda Carmeli, Pedro Póvoa, Antonio Alvarez Seoane, Pedro Henrique de Moura, Filipe Gonzalez, Paula Ramírez, Antonio Torres Martí, Ricard Ferrer, Lorena Oteiza, D. Escudero, Enrique Piacentini, Paula Vera, Luis Tamayo, Miguel Angel Gonzalez Gallego, B. Suberviola Cañas, Iglesias Figueira and 18 more - Critical Care 2022 cited by 93

  6. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock

    Authors: , , , , , , , , - Intensive Care Medicine 2011 cited by 353

  7. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bin Cao, Yahya Shehabi, Jens‐Ulrik Stæhr Jensen, Caspar Corti, Jos A. H. van Oers, Albertus Beishuizen, Armand R. J. Girbes, Evelien de Jong, Matthias Briel, Beat Müeller - The Lancet Infectious Diseases 2017 cited by 473

  8. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock

    Authors: , , , , , , , , , , , - Intensive Care Medicine 2016 cited by 476

  9. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome

    Authors: , , , , , , , , , , , , , - Intensive Care Medicine 2013 cited by 583

  10. Ventilator-associated Pneumonia

    Authors: , - American Journal of Respiratory and Critical Care Medicine 2002 cited by 2,815

  11. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yahya Shehabi, Albertus Beishuizen, Jens‐Ulrik Stæhr Jensen, Caspar Corti, Jos AH van Oers, Ann R. Falsey, Evelien de Jong, Carolina Oliveira, Bianca Beghé, Matthias Briel, Beat Müeller - Cochrane Database of Systematic Reviews 2017 cited by 648

  12. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia

    Authors: , , , - Current Opinion in Critical Care 2018 cited by 146

  13. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

    Authors: , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2019 cited by 131

  14. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre‐François Laterre, Didier Chochrad, Alain Dive, Frédéric Forêt, Marc A. Simon, Herbert Spapen, Jacques Créteur, Yves Bouckaert, Patrick Biston, Marc Bourgeois, Martin Nováček, Tomáš Vymazal, Petr Svoboda, Jan Pachl, Vladimír Šrámek, Michal Hanauer, Tomas Hruby, Martin Balík, Tomáš Suchý, Alain Lepape, Laurent Argaud, Frédéric Dailler, Arnaud Desachy, Christophe Guitton, Alain Mercat, Ferhat Meziani, Jean-Christophe Navellou, R. Robert, Bertrand Souweine, Jean‐Marc Tadié, Adel Maamar, Djillali Annane, Fabienne Tamion, Antoine Gros, Saad Nseir, Carole Schwebel, Gilles Francony, Jean‐Yves Lefrant, Francis Schneider, Matthias Gründling, J. Motsch, Lorenz Reill, Caroline Rolfes, Tobias Welte, Oliver A. Cornely, Frank Bloos, Maria Deja, Katrin Schmidt, Frank Wappler, Andreas Meier‐Hellmann, Apostolos Komnos, Vasileios Bekos, Vasilios Koulouras, Ioanna Soultati, Georgios Baltopoulos, Georgios Filntisis, Epaminondas Zakynthinos, Spyros Zakynthinos, Ioannis Pnevmatikos, Ildikó Krémer, Zoltán Szentkereszty, Ágnes Sárkány, Zsuzsa Marjanek, Pedro Henrique de Moura, Maria Consuelo Pintado Delgado, Juan Carlos Montejo González, Paula Ramírez, Antonio Torres Martí, Juan Carlos Valía, José A. Lorente and 6 more - The Lancet Infectious Diseases 2021 cited by 87

  15. Bedside Contribution of Electrical Impedance Tomography to Setting Positive End-Expiratory Pressure for Extracorporeal Membrane Oxygenation–treated Patients with Severe Acute Respiratory Distress Syndrome

    Authors: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2017 cited by 165

  16. Antibiotic stewardship in the intensive care unit

    Authors: , , , - Critical Care 2014 cited by 392

  17. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance

    Authors: , , , , , , , , , , , , , , - Critical Care 2015 cited by 273

  18. Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*

    Authors: , , , , , , , , , , - Critical Care Medicine 2014 cited by 207

  19. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock*

    Authors: , , , , , , , - Critical Care Medicine 2008 cited by 640

  20. Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

    Authors: , , , , , , , , - Clinical Infectious Diseases 2012 cited by 573

  21. Nosocomial Infections in Adult Cardiogenic Shock Patients Supported by Venoarterial Extracorporeal Membrane Oxygenation

    Authors: , , , , , , , , , , - Clinical Infectious Diseases 2012 cited by 314

  22. Antibiotic strategies in the era of multidrug resistance

    Authors: , , , - Critical Care 2016 cited by 299

  23. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Critical Care 2018 cited by 268

  24. Brain injury during venovenous extracorporeal membrane oxygenation

    Authors: , , , , , , , , , , , - Intensive Care Medicine 2016 cited by 258